{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:47:59Z","timestamp":1787737679116,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.urology.2024.06.029","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:02:45Z","timestamp":1718866965000},"page":"102-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical Upstaging After Neoadjuvant Chemotherapy Impacting Eligibility for Vaginal-sparing Cystectomy: Identifying Bladder Cancer Patients Who May Benefit From Interim Imaging"],"prefix":"10.1016","volume":"191","author":[{"given":"William J.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C.","family":"Haywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Eltemamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad","family":"Kaouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges-Pascal","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Weight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick M.","family":"Remer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Almassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2024.06.029_bib1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","volume":"59","author":"Stenzl","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.06.029_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eururo.2014.09.007","article-title":"Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"67","author":"Zargar","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.06.029_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clgc.2020.02.014","article-title":"Neoadjuvant gemcitabine-cisplatin plus radical cystectomy-pelvic lymph node dissection for muscle-invasive bladder cancer: a 12-year experience","volume":"18","author":"Iyer","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2024.06.029_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euo.2019.09.008","article-title":"A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients","volume":"3","author":"Russell","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2024.06.029_bib5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2017.05.016","article-title":"Oncologic outcomes for patients with residual cancer at cystectomy following neoadjuvant chemotherapy: a pathologic stage-matched analysis","volume":"72","author":"Bhindi","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.06.029_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bju.15579","article-title":"A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer","volume":"130","author":"Furrer","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.06.029_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JU.0000000000001381","article-title":"The need for interim assessment of neoadjuvant chemotherapy response for muscle invasive bladder cancer-can we help prevent definitive treatment delay in nonresponders?","volume":"205","author":"Regmi","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.06.029_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ucl.2017.12.005","article-title":"Role and indications of organ-sparing \u201cRadical\u201d cystectomy: the importance of careful patient selection and counseling","volume":"45","author":"Avulova","year":"2018","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2024.06.029_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clgc.2021.11.005","article-title":"Safety and efficacy of reproductive organ-sparing radical cystectomy in women with variant histology and advanced stage","volume":"20","author":"Patel","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2024.06.029_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jsxmed\/qdad012","article-title":"Why has sexuality research in women with bladder cancer undergoing radical cystectomy been ignored for so long?","volume":"20","author":"Vancavage","year":"2023","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2024.06.029_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JU.0000000000001784","article-title":"Contemporary rates of gynecologic organ involvement in females with muscle invasive bladder cancer: a retrospective review of women undergoing radical cystectomy following neoadjuvant chemotherapy","volume":"206","author":"Bree","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.06.029_bib12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s11255-006-9158-6","article-title":"Pathological review of internal genitalia after anterior exenteration for bladder cancer in women. Evaluating risk factors for female organ involvement","volume":"39","author":"Varkarakis","year":"2007","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2024.06.029_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijsu.2017.09.059","article-title":"Predictors of female genital organ involvement in radical cystectomy for urothelial carcinoma of the bladder: a\u00a0single-center retrospective analysis of 112 female patients","volume":"47","author":"Choi","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.urology.2024.06.029_bib14","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.juro.2012.08.024","article-title":"Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer","volume":"188","author":"Djaladat","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.06.029_bib15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.juro.2016.04.090","article-title":"Oncologic outcomes after anterior exenteration for muscle invasive bladder cancer in women","volume":"196","author":"Gregg","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.06.029_bib16","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.5489\/cuaj.5086","article-title":"Gynecological organ involvement at robot-assisted radical cystectomy in females:\u00a0is anterior exenteration necessary?","volume":"12","author":"Whittum","year":"2018","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urology.2024.06.029_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.euo.2022.04.008","article-title":"Contemporary staging for muscle-invasive bladder cancer: accuracy and limitations","volume":"5","author":"Hensley","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2024.06.029_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.06.029_bib19","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1007\/s00261-022-03669-0","article-title":"Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"47","author":"Jazayeri","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.urology.2024.06.029_bib20","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1007\/s00261-017-1449-0","article-title":"Bladder cancer local staging: multiparametric MRI performance following transurethral resection","volume":"43","author":"van der Pol","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.urology.2024.06.029_bib21","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1007\/s00330-020-06802-z","article-title":"Use of vesical imaging-reporting and data system (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis","volume":"30","author":"Luo","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urology.2024.06.029_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/bju.14366","article-title":"Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis","volume":"122","author":"Gandhi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.06.029_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/RCT.0000000000001012","article-title":"Assessment of the effectiveness of the vaginal contrast media in magnetic resonance imaging for detection of pelvic pathologies: a meta-analysis","volume":"44","author":"Unlu","year":"2020","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.urology.2024.06.029_bib24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.euo.2021.01.005","article-title":"Staging 18F-fluorodeoxyglucose positron emission tomography\/computed tomography changes treatment recommendation in invasive bladder cancer","volume":"5","author":"Voskuilen","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2024.06.029_bib25","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1007\/s00330-018-5959-0","article-title":"Integrated analysis of 18F-FDG PET\/CT improves preoperative lymph node staging for patients with invasive bladder cancer","volume":"29","author":"Girard","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urology.2024.06.029_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000488200","article-title":"Diagnostic accuracy of F-18 FDG PET\/CT for preoperative lymph node staging in newly diagnosed bladder cancer patients: a systematic review and meta-analysis","volume":"95","author":"Ha","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.urology.2024.06.029_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000528524","article-title":"Accuracy of FDG-PET\/CT for response evaluation of muscle-invasive bladder cancer following neoadjuvant or induction chemotherapy","volume":"107","author":"Fitoussi","year":"2023","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2024.06.029_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clgc.2018.05.008","article-title":"FDG-PET\/CT for assessing the response to neoadjuvant chemotherapy in bladder cancer patients","volume":"16","author":"Soubra","year":"2018","journal-title":"Clin Genitourin Cancer"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524004746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524004746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T12:11:41Z","timestamp":1730463101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429524004746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"alternative-id":["S0090429524004746"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2024.06.029","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Upstaging After Neoadjuvant Chemotherapy Impacting Eligibility for Vaginal-sparing Cystectomy: Identifying Bladder Cancer Patients Who May Benefit From Interim Imaging","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2024.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}